You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase products in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase formulations in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase formulations in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase formulations in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase products in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase products in section B

Nov 2024
Regimen
Published Date: 26 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated info on non-interchangeability of asparaginase products in section B

Nov 2024
Drug

Published Date: 20 Nov 2024

Revision Summary:
Drug Monograph: Updated Pregnancy and Lactation section
Nov 2024
Regimen
Published Date: 19 Nov 2024
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/breastfeeding section

Nov 2024
Regimen
Published Date: 19 Nov 2024
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy and Lactation section

Nov 2024
Regimen
Published Date: 19 Nov 2024
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures, Dose Modifications, and Pregnancy and Lactation sections

Nov 2024
Regimen
Published Date: 19 Nov 2024
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated pregnancy/lactation section

Nov 2024

Pages